"氨酸拉链蛋白作为新兴的治疗调节剂:结构动态,疾病关联和新的向策略"
Anjali Kumari1, Adiba Mussarrat1, Manodeep Chakraborty1
1Department of Pharmacology, Himalayan Pharmacy Institute, Majhitar, India.
Cell cycle (Georgetown, Tex.)
|November 6, 2025
概括
像C/EBPβ和GILZ这样的氨酸拉链蛋白调节代谢和免疫中的基因活性. 它们的不平衡导致炎症和疾病,但向疗法在治疗癌症和代谢障碍方面表现有前途.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
- 免疫学 免疫学 免疫学
背景情况:
- 氨酸拉链蛋白是通过DNA结合调节基因活性的转录因子.
- 它们在各种组织的新陈代谢,免疫力和应激反应中起着至关重要的作用.
- 特定的蛋白质,如C/EBPβ (肝脏,) 和GILZ (大脑,肺,免疫细胞) 有不同的功能.
研究的目的:
- 探索白氨酸拉链蛋白在生物过程中的调节作用.
- 了解它们失调在疾病发病过程中的影响.
- 审查针对这些蛋白质的潜在治疗策略.
主要方法:
- 关于氨酸拉链蛋白的功能和调节的文献综述.
- 分析C/EBPβ和GILZ在细胞过程中的作用.
- 检查与氨酸拉链蛋白失衡相关的疾病机制.
- 对当前和新兴治疗方法的调查.
主要成果:
- 氨酸拉链蛋白被荷尔蒙信号或氧化应激激活,转移到细胞核以调节基因表达.
- 像GILZ这样的蛋白质的损失与炎症和疾病的发展有关.
- 治疗策略包括小分子,和DNA诱疗法.
结论:
- 对氨酸拉链蛋白的选择性控制对于维持生物平衡至关重要.
- 有针对性的输送和生物标志物分析为治疗炎症性,代谢性和癌症疾病提供了潜力.
- 对这些蛋白质的进一步研究可能会打开新的治疗途径.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Covalently Linked Protein Regulators
2.0K
2.0K
Covalently Linked Protein Regulators
8.6K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
8.6K
Regulated Protein Degradation
3.1K
3.1K
Rab Proteins
4.9K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.9K


